C
Chris Mahida
Researcher at Jewish Hospital
Publications - 2
Citations - 22
Chris Mahida is an academic researcher from Jewish Hospital. The author has contributed to research in topics: Warfarin & Factor V Leiden. The author has an hindex of 2, co-authored 2 publications receiving 19 citations.
Papers
More filters
Journal ArticleDOI
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study
Parth Shah,Charles J. Glueck,Naila Goldenberg,Sarah Min,Chris Mahida,Ilana Schlam,Matan Rothschild,Ali Huda,Ping Wang +8 more
TL;DR: In patients with HeFH and/or CVD, LDLC was lowered by 63% on EVO and ALI 150 mg, and 54% on ALI 75 mg.
Journal ArticleDOI
Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy
Michael Ian Jarman,Kevin Lee,Ariel Kanevsky,Sarah Min,Ilana Schlam,Chris Mahida,Ali Huda,Alexander Milgrom,Naila Goldenberg,Charles J. Glueck,Ping Wang +10 more
TL;DR: Idiopathic ON, often caused by thrombophilia-hypofibrinolysis, is worsened by TT, and its progression may be slowed or stopped by discontinuation of TT and, thereafter, anticoagulation.